Danaher (DHR) financials
Danaher revenue and earnings by year
Danaher's revenue was $24.6 billion in the fiscal year to December 31, 2025, up 2.9% from the year before. Net income was $3.61 billion, 14.7% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 4.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.6 | 23.9 | 23.9 | 26.6 | 24.8 | 22.3 | 17.9 | 17.0 | 15.5 | 16.9 |
| Revenue growth | 2.9% | -0.1% | -10.3% | 7.4% | 11.3% | 24.4% | 5.1% | 9.9% | -8.1% | — |
| Gross profit | 14.5 | 14.2 | 14.0 | 16.2 | 15.2 | 12.5 | 10.0 | 9.5 | 8.6 | 9.3 |
| Gross margin | 59.1% | 59.5% | 58.7% | 60.8% | 61.4% | 56.0% | 55.7% | 55.8% | 55.2% | 55.3% |
| Operating income | 4.7 | 4.9 | 5.2 | 7.5 | 6.4 | 4.2 | 3.3 | 3.1 | 2.6 | 2.7 |
| Operating margin | 19.1% | 20.4% | 21.8% | 28.3% | 25.7% | 19.0% | 18.3% | 17.9% | 16.6% | 16.2% |
| Net income | 3.6 | 3.9 | 4.8 | 7.2 | 6.4 | 3.6 | 3.0 | 2.7 | 2.5 | 2.6 |
| Net margin | 14.7% | 16.3% | 19.9% | 27.1% | 25.9% | 16.4% | 16.8% | 15.5% | 16.1% | 15.1% |
| Diluted EPS | $5.05 | $5.29 | $5.81 | $8.53 | $7.61 | $4.32 | $3.58 | $3.30 | $3.12 | $2.81 |
| Free cash flow | 5.3 | 5.3 | 5.8 | 7.4 | 7.1 | 5.4 | 3.3 | 3.4 | 2.9 | 2.9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DHR in Markets.
How Danaher makes money
Revenue by segment in the quarter to September 25, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Diagnostics | $2.88B | 44.0% |
| Life Sciences | $1.86B | 28.5% |
| Biotechnology | $1.81B | 27.6% |
See also: DHR valuation and P/E history · DHR returns
No forecast, no recommendation. This page describes Danaher from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.